JAK2 mutation may predict response and guide first line treatment in rheumatoid arthritis

Abstract Background JAK (Janus kinase) inhibitors work by inhibiting the activity of one or more of the enzyme Janus kinase with a therapeutic application for treatment of cancer and inflammatory disorders such as rheumatoid arthritis (RA). We aimed to study impact of JAK2 mutation in serum of rheum...

Full description

Saved in:
Bibliographic Details
Main Authors: Yasmin Adel (Author), Mohamed Sabry (Author), Amr Mohamed El-Sabbagh (Author), Yousra Sadeq (Author)
Format: Book
Published: SpringerOpen, 2021-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available